ECOG: The Eastern Cooperative Oncology Group

General Information
 

ECOG
  Introduction to ECOG

Clinical Trials
  Guide For Cancer Patients
  What is a clinical trial?
  Why participate?
  Does insurance cover costs?
  What if I change my mind?
  How can I join a clinical trial?
  ECOG's active protocols
 Patient Information
  Selenium E5597
  GI Studies E4203,E5202,E5204
  Melanoma E2603

  Prostate CHAARTED E3805
  Cancer in Siblings E1Y97
  Non-Hodgkins Lymphoma E4402
  Breast Cancer PACCT1: TAILORx
  Informational Videos
  Trial Summary Results

Trial Monitoring
  ECOG Data Monitoring Committee

ECOG Institutions
  Institutions by state
  Alphabetical listing
  Joining ECOG

Publications
  Publications bibliography
 
Announcements
  TAILORx Webinar Information
  NCI Press Release: Bevacizumab...
  Job Openings
  Future ECOG Meeting Dates
  Researcher Advocate Partners
  Investigator Awards
  NCI-VA Initiative

Scales and Criteria
  ECOG Performance Status
  Common Toxicity Criteria

Cancer Information
  Breast Cancer Video
  Colon Cancer Video
  Cancer Survivor Publications
  Releasing Results Guidelines

Other Cancer Sites
  ECOG Main Institutions' Sites
  Other Cooperative Groups
  Advocates/Support Groups
 

ECOG HOME PAGE

ECOG MEMBERS
INFORMATION

(password required)

GLOSSARY

SEARCH

CONTACT INFORMATION

DISCLAIMER

                    

Eastern Cooperative Oncology Group:

E4Z02 Trial For Cancer Patients With Fatigue

You can learn more about this trial by viewing a short informational video featuring Dr. Ricardo Cruciani, the study chair for this trial:

Click here for a list of institutions participating in this trial

Note to institutions: Use of these videos for patient education requires approval of your institution's IRB.

E4Z02 is looking at the potential value of taking l-carnitine as a supplement to combat cancer-related fatigue.

Patients participating in the study will be randomized to receive either l-carnitine or a placebo for four weeks, after which all participants will receive l-carnitine for an additional four weeks. Patients will be be evaluated for Quality of Life and fatigue symptoms at the beginning of the study, at the four week point and at the conclusion of the study.

You can learn more about treating cancer-related fatigue and anemia and about prostate cancer by visiting these web sites:


National Cancer Institute Information On Fatigue

American Cancer Society Information On Fatigue

Information about cancer clinical trials can be found at:

National Cancer Institute Clinical Trials Information

CancerTrials Help - Coalition of Cancer Cooperative Groups